A More Pleasant Way
to Screen for Colon Cancer


Our Shield™ blood test is now FDA-approved for use in adults age 45 and older who are at average risk of colorectal cancer.

A Blood Test to Screen for Early Signs of Cancer

Our Shield blood test offers individuals a more pleasant and convenient screening option that helps overcome barriers associated with available methods, including colonoscopy and stool-based testing, which can be unpleasant, time-consuming and difficult to complete.

Cancer screening is a proven way to detect cancer early, when it’s most treatable. However, 1 in 3 eligible Americans do not complete colorectal cancer screening in part because they find the current options unpleasant or inconvenient.1

Blood-based screening tests like Shield that can be completed as part of a simple blood draw have the potential to improve screening adherence and identify more cancers early, when they are most treatable.

Our ECLIPSE study validates Shield as a high-sensitivity blood test for colorectal cancer screening.

Learn More About Shield

Interested in learning more about our Shield blood test for early cancer screening?

Visit ShieldCancerScreen.com